Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
10
|
pubmed:dateCreated |
1993-2-23
|
pubmed:abstractText |
We wished to assess the efficacy of inhaled salmeterol (SML; 50 micrograms b.i.d.) compared to a combination of slow-release theophylline and ketotifen p.o. (TK; T 300 mg+K 1 mg b.i.d.) for the treatment of nocturnal asthma. Ninety six patients with nocturnal asthma, (forced expiratory volume in one second (FEV1) 60-90% of predicted value, reversibility > or = 15%, at least two nocturnal awakenings per week) were eligible for a multicentre, double-blind, double-dummy cross-over study (14-day run-in, two successive 28-day treatment periods). Efficacy was assessed as success/failure, success being defined as the complete disappearance of nocturnal symptoms/awakening during the last week of each treatment period. There was a statistically significant difference between SML and TK for this criterion: 46% and 39% success with SML during periods I (first 28-day period) and II (following the cross-over), compared to only 15% and 26% with TK, respectively (p < 0.01). SML was also significantly better for the other criteria (lung function, rescue salbutamol intake during day and night). Side-effects were five times less frequent in SML-treated patients (p < 0.004). Efficacy and tolerance of SML were obviously far better than those of TK in patients with nocturnal asthma.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Albuterol,
http://linkedlifedata.com/resource/pubmed/chemical/Bronchodilator Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Delayed-Action Preparations,
http://linkedlifedata.com/resource/pubmed/chemical/Ketotifen,
http://linkedlifedata.com/resource/pubmed/chemical/Theophylline,
http://linkedlifedata.com/resource/pubmed/chemical/salmeterol
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0903-1936
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
5
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1197-200
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:1486965-Administration, Inhalation,
pubmed-meshheading:1486965-Administration, Oral,
pubmed-meshheading:1486965-Adolescent,
pubmed-meshheading:1486965-Adult,
pubmed-meshheading:1486965-Aged,
pubmed-meshheading:1486965-Albuterol,
pubmed-meshheading:1486965-Asthma,
pubmed-meshheading:1486965-Bronchodilator Agents,
pubmed-meshheading:1486965-Circadian Rhythm,
pubmed-meshheading:1486965-Delayed-Action Preparations,
pubmed-meshheading:1486965-Double-Blind Method,
pubmed-meshheading:1486965-Drug Therapy, Combination,
pubmed-meshheading:1486965-Female,
pubmed-meshheading:1486965-Humans,
pubmed-meshheading:1486965-Ketotifen,
pubmed-meshheading:1486965-Male,
pubmed-meshheading:1486965-Middle Aged,
pubmed-meshheading:1486965-Theophylline
|
pubmed:year |
1992
|
pubmed:articleTitle |
Salmeterol versus slow-release theophylline combined with ketotifen in nocturnal asthma: a multicentre trial. French Multicentre Study Group.
|
pubmed:affiliation |
Service de Pneumologie, Höpital de Bois Guillaume, France.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Multicenter Study
|